. . . . . . . "[High BCL2 expression predicted poor relapse-free survival (RFS) in patients treated with anthracycline-based adjuvant chemotherapy (p?=?0.035), poor breast cancer-specific survival (BCSS) (p?=?0.048), and a trend to poor overall survival (OS) (p?=?0.085).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:10:53+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .